Delivery Order SPE2DB22D2005-SPE2DB26FJEP2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in a 30-gram unit, with a contract value of $1,125.26. This is a firm fixed-price delivery order with no set-aside designation, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 100-gram quantities, with a ceiling value of $1,704.94. This contract, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizes firm fixed-price pricing and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a $1,207.19 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 30-gram units under a firm fixed-price contract with an ultimate completion date of September 23, 2025. This is a non-set-aside, competitively awarded delivery order executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,557.56 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This non-competitive, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,024.44 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 30-gram units, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and utilizes a child delivery order structure under AmerisourceBergen's larger contract vehicle with DLA. The product will be performed from the vendor's facility in Conshohocken, Pennsylvania, supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 100-gram quantities, with a ceiling value of $2,181.45. The contract was competitively awarded without set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,002.95 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $2,458.75 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 100-gram units, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $1,484.50. This firm fixed-price delivery order, with an ultimate completion date of July 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $4,484.65 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram quantities. This is a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, issued on October 27, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJEP2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,569.84 to supply Pimecrolimus 1% Cream in 30-gram units. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of October 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete procurement action under the company's broader relationship with the federal government's military medical supply chain. This award is a child contract issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion and extending through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of generic and brand-name medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements through competitive contracting, with a portfolio spanning diabetes medications, neurological treatments, pain management products, antibiotics, and specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/27/25 |